Inovio Pharmaceuticals Inc (INO)
4.06
+0.09
(+2.27%)
USD |
NASDAQ |
Nov 21, 16:00
4.065
0.00 (0.00%)
After-Hours: 20:00
Inovio Pharmaceuticals Shares Outstanding: 26.10M for Nov. 13, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
November 13, 2024 | 26.10M |
September 30, 2024 | 26.05M |
August 08, 2024 | 25.96M |
June 30, 2024 | 25.96M |
May 10, 2024 | 25.91M |
April 18, 2024 | 25.91M |
March 31, 2024 | 23.37M |
March 25, 2024 | 23.37M |
March 01, 2024 | 23.37M |
January 25, 2024 | 22.75M |
January 24, 2024 | 22.75M |
December 31, 2023 | 22.79M |
November 16, 2023 | 22.75M |
November 08, 2023 | 22.75M |
September 30, 2023 | 22.48M |
August 07, 2023 | 22.34M |
June 30, 2023 | 22.34M |
May 08, 2023 | 21.90M |
March 31, 2023 | 21.89M |
March 17, 2023 | 21.89M |
February 24, 2023 | 21.68M |
December 31, 2022 | 21.09M |
November 07, 2022 | 20.79M |
September 30, 2022 | 20.79M |
August 05, 2022 | 20.78M |
Date | Value |
---|---|
June 30, 2022 | 20.63M |
May 09, 2022 | 19.09M |
March 31, 2022 | 18.88M |
March 17, 2022 | 18.48M |
February 25, 2022 | 18.12M |
December 31, 2021 | 18.12M |
November 05, 2021 | 17.53M |
September 30, 2021 | 17.53M |
August 06, 2021 | 17.53M |
June 30, 2021 | 17.51M |
May 06, 2021 | 17.45M |
March 31, 2021 | 17.44M |
March 16, 2021 | 17.36M |
February 26, 2021 | 17.30M |
January 25, 2021 | 17.05M |
December 31, 2020 | 15.57M |
November 05, 2020 | 14.12M |
September 30, 2020 | 13.96M |
August 07, 2020 | 13.96M |
June 30, 2020 | 13.23M |
May 08, 2020 | 13.17M |
April 30, 2020 | 13.17M |
March 31, 2020 | 12.16M |
March 17, 2020 | 12.15M |
March 11, 2020 | 12.15M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
8.447M
Minimum
Dec 31 2019
26.10M
Maximum
Nov 13 2024
19.26M
Average
19.86M
Median
Shares Outstanding Benchmarks
Novavax Inc | 160.18M |
Baxter International Inc | 510.59M |
AIM ImmunoTech Inc | 63.71M |
Protalix BioTherapeutics Inc | 73.63M |
Armata Pharmaceuticals Inc | 36.18M |